Skip to main content
. Author manuscript; available in PMC: 2010 Oct 20.
Published in final edited form as: Brain Res. 2009 Jan 10;1259:51–58. doi: 10.1016/j.brainres.2008.12.067

Table 2.

EB treatment increased 5-HTT mRNA levels in the midbrain raphe nuclei of OVX rats.

EB treatment (μg)
Brain areas 0 2 10 F-values
tissue section 112 ± 14
(100 ± 13 %)		 302 ± 42*
(271 ± 38 %)		 252 ± 23*
(226 ± 20 %)		 F(2,14) = 9.58, P < 0.005
DRN 511 ± 63
(100 ± 12 %)		 1028 ± 151*
(201 ± 30 %)		 943 ± 86*
(184 ± 17 %)		 F(2,14) = 5.53, P < 0.05
DRV 223 ± 39
(100 ± 18 %)		 486 ± 78*
(218 ± 35 %)		 484 ± 43*
(218 ± 19 %)		 F(2,14) = 6.20, P < 0.05
DRD 124 ± 38
(100 ± 31 %)		 163 ± 31
(132 ± 24 %)		 164 ± 22
(132 ± 17 %)		 F(2,14) = 0.55, n.s.
DRL 142 ± 52
(100 ± 37 %)		 264 ± 51
(186 ± 36 %)		 227 ± 23
(160 ± 16 %)		 F(2,14) = 2.06, n.s.
MRN 132 ± 34
(100 ± 26 %)		 173 ± 37
(131 ± 28 %)		 149 ± 17
(113 ± 13 %)		 F(2,14) = 0.45, n.s.

5-HTT mRNA levels were determined by the product of pixel density × pixel number (in thousands). Data are also expressed (in parentheses) as a percent of the mean of the 0 μg EB-treated (control) group.

*

Greater than 0 μg EB-treated (control) group, Ps < 0.05.